KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 99 filers reported holding KYMERA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,558,740 | +11.4% | 184,082 | +84.2% | 0.00% | 0.0% |
| Q2 2023 | $2,297,046 | -17.5% | 99,915 | +6.3% | 0.00% | 0.0% |
| Q1 2023 | $2,785,664 | +40.4% | 94,015 | +18.2% | 0.00% | +50.0% |
| Q4 2022 | $1,984,694 | +14.4% | 79,515 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $1,735,000 | +14.9% | 78,615 | +2.5% | 0.00% | 0.0% |
| Q2 2022 | $1,510,000 | -57.2% | 76,676 | -8.1% | 0.00% | -33.3% |
| Q1 2022 | $3,532,000 | -37.0% | 83,462 | -5.5% | 0.00% | -40.0% |
| Q4 2021 | $5,607,000 | +40.5% | 88,320 | +29.9% | 0.01% | +25.0% |
| Q3 2021 | $3,992,000 | +2.6% | 67,965 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $3,892,000 | +276.4% | 64,665 | +143.1% | 0.00% | +300.0% |
| Q1 2021 | $1,034,000 | -27.5% | 26,599 | +15.6% | 0.00% | -50.0% |
| Q4 2020 | $1,426,000 | +98.9% | 23,001 | +3.6% | 0.00% | +100.0% |
| Q3 2020 | $717,000 | – | 22,201 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,984,736 | $149,379,011 | 17.99% |
| Aquilo Capital Management, LLC | 629,411 | $15,710,099 | 5.90% |
| BVF INC/IL | 4,692,604 | $117,127,396 | 4.94% |
| Artal Group S.A. | 2,000,000 | $49,920 | 2.79% |
| Redmile Group, LLC | 2,673,837 | $66,738,972 | 2.73% |
| Avoro Capital Advisors LLC | 3,850,000 | $96,096,000 | 1.44% |
| Deer Management Co. LLC | 615,895 | $15,372,739 | 1.42% |
| AtonRa Partners | 27,125 | $677,040 | 0.86% |
| Rock Springs Capital Management LP | 1,227,779 | $30,645,364 | 0.74% |
| EcoR1 Capital, LLC | 796,093 | $19,870,481 | 0.60% |